Allergan (NYSE: AGN) and KYTHERA Biopharmaceuticals, Inc. (Nasdaq: KYTH) announced that the U.S. Federal Trade Commission (FTC) has granted early ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Mergers and Acquisitions

Canaccord Genuity Raises Price Target on Allergan (AGN) Following Announced Generics Sale July 28, 2015 9:13 AM Leerink Partners Raised Price Target on Allergan (AGN) to $388 Following TEVA Announcement July 28, 2015 8:19 AM Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERAJuly 27, 2015 4:45 PM Allergan CEO, fresh off one deal, sets sights on othersJuly 27, 2015 11:52 AM